Senior Editor, Diagnostic Imaging
Digital Breast Tomosynthesis and Breast Density: What a New Study RevealsOctober 6th 2022
In a large study of nearly 100,000 women, researchers found that the combination of digital breast tomosynthesis (DBT) and synthesized mammography had more than triple the detection rate for invasive breast cancer in extremely dense breasts in comparison to digital mammography alone.
Study Looks at Potential Impact of Expanded Eligibility for Low-Dose CT Lung Cancer ScreeningOctober 6th 2022
Modifications to pack-year history and smoking quit duration thresholds beyond those recommended in the 2021 United States Preventative Services Task Force (USPSTF) criteria for low-dose computed tomography lung cancer screening may more than double the number of increased lung cancer cases physicians would see with application of the 2021 USPSTF screening criteria.
Study Finds No Benefit to MRI Screening in Women with High-Risk Breast LesionsOctober 3rd 2022
In a study involving nearly 700 patients with atypical ductal or lobular hyperplasia, or lobular carcinoma in situ, researchers found no difference in four-year breast cancer detection rates between women who had screening mammography and breast magnetic resonance imaging (MRI), and women who only had mammography screening.
Prospective MRI Study Reveals Impact of Opioid Exposure on the Fetal BrainSeptember 30th 2022
Researchers found that in utero opioid exposure resulted in seven out of 14 2D biometric measurements of the fetal brain being smaller on magnetic resonance imaging (MRI) scans in comparison to fetuses without opioid exposure.
MRI Deep Learning Software from GE Healthcare Gets Expanded FDA ClearanceSeptember 29th 2022
AIR Recon DL, a deep learning-based image reconstruction software, will now be available with 3D sequences as well as PROPELLER motion-insensitive sequences on magnetic resonance imaging (MRI) scanners from GE Healthcare.
A Closer Look at Ultrasound and MRI Alternatives for Head and Neck ImagingSeptember 29th 2022
In light of recent shortages of iodinated contrast media, researchers from Australia suggest in a new publication that ultrasound and magnetic resonance imaging (MRI) can be viable first-line imaging options for a number of non-urgent presentations of the head and neck.
What a New Meta-Analysis Reveals About Breast Density, Mammography and MRI ScreeningSeptember 28th 2022
Assessing data from 386,590 women, researchers noted that women with extremely dense breast tissue have more than double the risk for breast cancer in comparison to women with average breast density and nearly four times the risk of women with extremely fatty breast tissue.
FDA to Review Blue Earth Diagnostics' Emerging PSMA/PET Agent for Prostate CancerSeptember 27th 2022
One prospective multicenter study found the radiohybrid prostate-specific membrane antigen (PSMA) agent 18F-rhPSMA-7.3 had an 83 percent detection rate in nearly 400 men with suspected prostate cancer.
Five Takeaways from New Consensus Recommendations for CT Imaging and Reporting in Patients with CADSeptember 23rd 2022
In an update of the original CAD-RADS™ consensus document on coronary artery disease (CAD) imaging and reporting published in 2016, expert panelists incorporated emerging evidence for CAD-RADS 2.0 to recommend new categorization for coronary plaque burden and suggested modifiers to reflect the level of ischemia and high-risk plaque in patients undergoing cardiac computed tomography.
Ultrasound-Based Breast Imaging Device Gets FDA Clearance for Fibroglandular Volume MetricsSeptember 23rd 2022
The ability of QT Imaging’s QTscan, a quantitative transmission ultrasound modality, to calculate the ratio of fibroglandular volume to total breast volume may facilitate assessment of ongoing breast cancer treatments or selective hormone receptor modulation therapies.
FDA Approves New MRI Contrast Agent GadopiclenolSeptember 22nd 2022
Requiring only half of the gadolinium dose of current non-specific gadolinium-based contrast agents (GBCAs), gadopiclenol can be utilized with magnetic resonance imaging (MRI) to help detect lesions with abnormal vascularity in the central nervous system and other areas of the body.
New Mammography Study Examines Association Between Breast Density Changes and Breast Cancer RiskSeptember 22nd 2022
In a retrospective review involving over 2.2 million women with three consecutive biennial mammography screenings and no history of breast cancer, researchers noted that for premenopausal women with fatty breasts at baseline, increasing breast density at subsequent screenings led to significantly elevated hazard ratios ranging from 1.45 to 1.93 for the risk of breast cancer.
Study Shows Adjunctive Benefit of Pre-Biopsy MRI for Diagnosing Prostate CancerSeptember 20th 2022
Emerging research suggests that combining pre-biopsy magnetic resonance imaging (MRI) with prostate-specific antigen (PSA) testing more than triples the specificity rate for detecting clinically significant prostate cancer in comparison to sole reliance on a PSA level greater than or equal to 4 ng/mL.
Post-Vaccine Axillary Lymphadenopathy: What a New Chest MRI Study RevealsSeptember 19th 2022
In a new study looking at the development of axillary lymphadenopathy after a second dose of COVID-19 vaccination, researchers found that those who had the Moderna COVID-19 vaccine were 21 percent more likely to have the post-vaccine side effect in comparison to those who had the Pfizer-BioNtech COVID-19 vaccine.
FDA Grants 510(k) Clearance to Chiropractic Straight Arm Radiography SystemSeptember 16th 2022
Combining low-cost, high-resolution radiography with dynamic imaging capabilities and design attributes to optimize workflow efficiency, the Chiropractic Straight Arm system may enhance musculoskeletal imaging.
Philips Set to Launch FetView Fetal Ultrasound Platform at ISUOG ConferenceSeptember 15th 2022
Emphasizing the digitalization of OB/GYN workflows and patient management, the cloud-based system reportedly facilitates real-time access to fetal ultrasound images and related data from any ultrasound system.
What a New Study Reveals About Radiographers and Mammography AssessmentSeptember 14th 2022
In a new United Kingdom study comparing radiologist and radiographer assessment of over 1.4 million digital mammograms, researchers said there were no significant differences with cancer detection rates or recall rates.
Could a New Deep Learning Tool Enhance CT Detection of Pancreatic Cancer?September 13th 2022
New research reveals that an emerging deep learning tool had comparable sensitivity and specificity to radiologist assessment of contrast-enhanced computed tomography (CT) scans for pancreatic cancer, and a 74.7 percent sensitivity rate for tumors smaller than 2 cm.
CT AI Software for Fracture Risk Gets Breakthrough Device Designation from FDASeptember 13th 2022
Assessing high-resolution computed tomography (CT) scans of the wrist, CurveBeam AI’s OssView software reportedly enables clinicians to ascertain bone fragility and fracture risk for women over the age of 70.
Samsung Gets FDA Nod for Versatile V7 Ultrasound SystemSeptember 9th 2022
Offering uniform high-resolution images through a combination of beamforming and enhanced image processing, the new ultrasound platform reportedly has an array of diagnostic features ranging from cardiovascular applications to breast lesion assessment.
Could the New Stratus Imaging PACS Viewer Help Streamline Radiology Workflows?September 9th 2022
Offering a variety of features to enhance efficiency, bolster security and reduce IT overhead, the cloud-native SaaS platform may help radiologists minimize workflow issues that can impede practices with high imaging volume.
New Study Suggests Lung-Related Comorbidities Have No Impact on Lung Cancer DetectionSeptember 8th 2022
Comparing patients with and without comorbidities ranging from emphysema and tuberculosis to chronic obstructive pulmonary disease (COPD), researchers found that cancer detection rates and false-positive rates remained similar in lung cancer screening.
Study: Deep Learning System is Comparable to Radiologist Assessment of Chest X-Rays for TuberculosisSeptember 7th 2022
Examining imaging data of patients from multiple countries, researchers found that a deep learning system demonstrated higher sensitivity and non-inferior specificity for detecting active tuberculosis on chest radiographs in comparison to nine radiologist reviewers.
Will a New Spectral CT Imaging Suite Reinvent Interventional Radiology?September 7th 2022
Amid emerging research showing the benefits of spectral computed tomography (CT) imaging in interventional radiology, the newly launched Phillips Spectral Angio CT Suite may provide enhanced efficiencies in care for stroke, oncology, and trauma patients.
Emerging AI CT Tool May Provide Viable Complement to Lung-RADS ClassificationSeptember 6th 2022
Researchers suggest that an artificial intelligence (AI)-powered risk stratification tool for lung nodules identified on computed tomography (CT) scans may identify likely malignancies more than one year prior to definitive diagnosis.